Substituted indoles and their use as hcv inhibitors
CA 2501547 A1 · Owner: Darwish, Ihab S. · Inventors: Darwish, Ihab S.; Thota, Sambaiah; Kolluri, Rao S. S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention comprises indole-derivatives that are inhibitors of HCV. Composition comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell particular in the form of , treating HCV infection in a mammal.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 15, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 15, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 15, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.